A study on vancomycin treatment, new data on the investigational Pfizer C diff vaccine, how individual antibiotics are ranked by risk for C difficile infection, and more.
New Genomic Study Reveals Hidden Pathways of C difficile Transmission in Hospitals
C difficile, Antimicrobials, and the Patients Most Affected
New Meta-Analysis Highlights Most Effective Treatments for Clostridioides difficile Infection
Investigational Live Biotherapeutic Product Significantly Reduces Risk of Recurrent Clostridioides difficile
LPOXY Therapeutics Acquires Assets to Advance C difficile Protection for Antibiotic Patients
Contagion's 2024 Top Stories: C difficile